Expand RPRX Menu
RPRX MENU

RPRX Latest Press Releases

-- February 11, 2026 --

Royalty Pharma Reports Q4 and Full Year 2025 Results Globe Newswire 7:00 AM

-- January 20, 2026 --

Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 Globe Newswire 4:15 PM

-- January 12, 2026 --

Royalty Pharma to Highlight Accomplishments and Provide Business Update at 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 7:15 AM

-- January 11, 2026 --

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo Globe Newswire 5:15 PM
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo Globe Newswire 5:00 PM

-- January 9, 2026 --

Royalty Pharma Announces Dividend Increase Globe Newswire 8:30 AM

-- December 29, 2025 --

Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones Globe Newswire 4:40 PM

-- December 16, 2025 --

Royalty Pharma Acquires Royalty Interest in Nuvalent's Neladalkib and Zidesamtinib for Up to $315 Million Globe Newswire 7:15 AM

-- December 12, 2025 --

Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance PRNewswire 10:48 AM

-- December 4, 2025 --

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement Globe Newswire 7:10 AM
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement Globe Newswire 7:00 AM

-- November 26, 2025 --

Royalty Pharma to Present at Upcoming Investor Conferences Globe Newswire 8:15 AM

-- November 5, 2025 --

Royalty Pharma Reports Third Quarter 2025 Results Globe Newswire 7:00 AM

-- November 4, 2025 --

Royalty Pharma Acquires Royalty Interest in Alnylam's AMVUTTRA for $310 Million from Blackstone Life Sciences Globe Newswire 7:15 AM

-- October 17, 2025 --

Royalty Pharma Declares Fourth Quarter 2025 Dividend Globe Newswire 8:15 AM

-- October 9, 2025 --

Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025 Globe Newswire 4:15 PM

-- September 29, 2025 --

Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director Globe Newswire 8:15 AM

-- September 19, 2025 --

Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum Globe Newswire 4:25 PM
Market Data Delayed 15 Minutes